Eileen Murray, co-chief executive officer of Bridgewater Associates LP, speaks during the Bloomberg Business of Equality conference in New York, U.S., on Tuesday, May 8, 2018. Mark Kauzlarich | Bloomberg | Getty Images A co-CEO of the world’s largest hedge fund, Bridgewater Associates, is considering leaving the fund, The Wall Street Journal reported on Monday.
0 Comments
Glenview Capital Management CEO Larry Robbins said Monday that he’s shorting shares of industrial conglomerate 3M. Robbins underscored 3M’s mounting litigation headaches, which span multiple states and center on pollution as a result of its operations. The manager added that, since 2015, 3M’s lawsuits have soared 87 fold and now pose a significant liability to
0 Comments
Adam Jeffery | CNBC Bihua Chen, founder and portfolio manager at Cormorant Asset Management, said on Monday she likes kidney disease drug maker Reata Pharmaceuticals. The kidney drug that Reata is developing called Bardoxolone has “striking efficacy,” the hedge fund manager said from the Sohn Conference in New York. Shares of Reata Pharmaceutical jumped more
0 Comments